← Back to headlines

Ozempic-Type Drugs Show Promise in Breast Cancer Prevention
New research suggests that anti-obesity drugs, specifically GLP-1 agonists like Ozempic, may offer a new pathway for preventing breast cancer by linking their use to a lower incidence of the disease.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.



